Back to today’s briefing

Story perspectives

New Drug KCL-HO-1i Boosts Chemotherapy Against Resistant Tumors

8/11/2025

35 6

Summary

Story summary

A groundbreaking drug, KCL-HO-1i, has been developed by researchers at King's College London to combat tumors' defenses against chemotherapy. Promising early tests on mice reveal its potential to boost chemotherapy's power, even against resistant tumors. With human trials on the horizon, this innovation could revolutionize cancer treatment in the near future.

1 of 1

Story summary

A groundbreaking drug, KCL-HO-1i, has been developed by researchers at King's College London to combat tumors' defenses against chemotherapy. Promising early tests on mice reveal its potential to boost chemotherapy's power, even against resistant tumors. With human trials on the horizon, this innovation could revolutionize cancer treatment in the near future.